MARAVAI LIFESCIENCES HOLDINGS, INC. (Nasdaq:MRVI)

Health Care/Life Sciences • Biotechnology

CIK 1823239

Company

Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.

Address
10770 Wateridge Circle
Suite 200
San Diego, California 92121

Employees
650

Stock Info

Close
$8.94

Day Range
8.84 - 9.10

52 Week Range
4.52 - 12.92

Average volume
2.1M

Short Interest
6.88M (06/28/24)

% of Float Shorted
6.28%

Market Cap
$2.25B

Revenue
$288.95M

Net Income
-$119.03M

2020 Sales Growth
N/A

Rev. per Employee
$421.69K

P/E Ratio
N/A

EPS
-$0.99

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Executive Chairman
Carl W Hull MBA

Director
Sean Laurence Cunningham MBA

Director
Benjamin J Daverman MBA

Director
Luke Marker MBA

Director
Murali K Prahalad PhD

Director
John A DeFord PhD

Independent Director
Susannah Gray MBA

Independent Director
Anat Ashkenazi MBA

Independent Director
Jessica Hopfield PhD, MBA

Independent Director
Gregory T Lucier MBA

Independent Director
Dean Spyro Mihas MBA

SEC filings

Date	Form	Event
8 Aug, 2024	10-Q
7 Aug, 2024	8-K
29 Jul, 2024	8-K
16 Jul, 2024	4
12 Jun, 2024	8-K
10 Jun, 2024	SC 13G
30 May, 2024	4
28 May, 2024	144
28 May, 2024	8-K
28 May, 2024	144
24 May, 2024	4
24 May, 2024	4
24 May, 2024	4
24 May, 2024	4
24 May, 2024	4
24 May, 2024	4
24 May, 2024	4
24 May, 2024	4
24 May, 2024	4
24 May, 2024	4
14 May, 2024	SC 13G
9 May, 2024	10-Q
8 May, 2024	8-K
2 May, 2024	4
2 May, 2024	4
2 May, 2024	4
2 May, 2024	4
2 May, 2024	4
25 Apr, 2024	ARS
25 Apr, 2024	DEF 14A
16 Apr, 2024	4
18 Mar, 2024	4
18 Mar, 2024	4
18 Mar, 2024	4
18 Mar, 2024	4
18 Mar, 2024	4
18 Mar, 2024	4
29 Feb, 2024	10-K
28 Feb, 2024	SC 13G/A
22 Feb, 2024	8-K
20 Feb, 2024	4
20 Feb, 2024	4
20 Feb, 2024	4
20 Feb, 2024	4
14 Feb, 2024	SC 13G
14 Feb, 2024	SC 13G
13 Feb, 2024	SC 13G/A
8 Feb, 2024	SC 13G/A
18 Jan, 2024	4
18 Jan, 2024	4
18 Jan, 2024	4
18 Jan, 2024	4
18 Jan, 2024	4
18 Jan, 2024	4
18 Jan, 2024	4
18 Jan, 2024	5
18 Jan, 2024	4
5 Jan, 2024	SC 13G/A
16 Nov, 2023	4
16 Nov, 2023	4
16 Nov, 2023	4
16 Nov, 2023	4
8 Nov, 2023	10-Q
7 Nov, 2023	8-K
7 Nov, 2023	SC 13G/A
26 Oct, 2023	SC 13G
17 Oct, 2023	4
22 Aug, 2023	4
8 Aug, 2023	10-Q
7 Aug, 2023	8-K
27 Jul, 2023	8-K	CEO Change
21 Jul, 2023	4
20 Jul, 2023	8-K
20 Jul, 2023	3
19 Jul, 2023	4
19 Jul, 2023	4
19 Jul, 2023	4
19 Jul, 2023	4
19 Jul, 2023	4
19 Jul, 2023	4
19 Jul, 2023	4
19 Jul, 2023	4
19 Jul, 2023	4
19 Jul, 2023	4
19 Jul, 2023	4
19 Jul, 2023	4
19 Jul, 2023	4
22 May, 2023	8-K
9 May, 2023	10-Q
8 May, 2023	8-K
20 Apr, 2023	DEF 14A
20 Apr, 2023	ARS
6 Apr, 2023	3
6 Apr, 2023	3
17 Mar, 2023	4
17 Mar, 2023	4
17 Mar, 2023	4
17 Mar, 2023	4
17 Mar, 2023	4
13 Mar, 2023	8-K
10 Mar, 2023	8-K
28 Feb, 2023	10-K
22 Feb, 2023	8-K
17 Feb, 2023	4
17 Feb, 2023	4
17 Feb, 2023	4
17 Feb, 2023	4
17 Feb, 2023	4
14 Feb, 2023	SC 13G/A
9 Feb, 2023	SC 13G/A
8 Feb, 2023	SC 13G/A
24 Jan, 2023	4
1 Dec, 2022	8-K
10 Nov, 2022	SC 13G/A
9 Nov, 2022	4
9 Nov, 2022	4
9 Nov, 2022	4
4 Nov, 2022	10-Q
2 Nov, 2022	8-K
19 Oct, 2022	8-K
19 Oct, 2022	4
5 Oct, 2022	3
3 Oct, 2022	8-K	CEO Change
6 Sep, 2022	SC 13G/A
6 Sep, 2022	SC 13G/A
5 Aug, 2022	10-Q
4 Aug, 2022	8-K
28 Jul, 2022	UPLOAD
19 Jul, 2022	4
12 Jul, 2022	CORRESP
11 Jul, 2022	SC 13G/A
29 Jun, 2022	UPLOAD
28 Jun, 2022	3
27 Jun, 2022	4
27 Jun, 2022	4
27 Jun, 2022	4/A
27 Jun, 2022	4
27 Jun, 2022	4/A
27 Jun, 2022	4
27 Jun, 2022	4/A
16 May, 2022	8-K
6 May, 2022	10-Q
14 Apr, 2022	DEF 14A
1 Mar, 2022	10-K
23 Feb, 2022	8-K
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
11 Feb, 2022	SC 13G/A
10 Feb, 2022	SC 13G/A
9 Feb, 2022	SC 13G/A
2 Feb, 2022	SC 13G
1 Feb, 2022	4
28 Jan, 2022	8-K
27 Jan, 2022	4
27 Jan, 2022	4
27 Jan, 2022	4
27 Jan, 2022	4
27 Jan, 2022	4
20 Jan, 2022	8-K
4 Jan, 2022	4
3 Jan, 2022	8-K
23 Nov, 2021	4
23 Nov, 2021	4
23 Nov, 2021	4
23 Nov, 2021	4
23 Nov, 2021	4
23 Nov, 2021	4
23 Nov, 2021	4
23 Nov, 2021	4
23 Nov, 2021	4
23 Nov, 2021	4
15 Nov, 2021	10-Q
10 Nov, 2021	8-K
9 Nov, 2021	SC 13G
13 Sep, 2021	424B4
13 Sep, 2021	4
9 Sep, 2021	EFFECT
7 Sep, 2021	S-1
7 Sep, 2021	CORRESP
7 Sep, 2021	CORRESP
3 Sep, 2021	8-K
31 Aug, 2021	UPLOAD
26 Aug, 2021	DRS
11 Aug, 2021	10-Q
10 Aug, 2021	8-K
20 May, 2021	8-K
12 May, 2021	10-Q
10 May, 2021	8-K
19 Apr, 2021	DEF 14A
12 Apr, 2021	SC 13G/A
9 Apr, 2021	PRE 14A
9 Apr, 2021	424B4
9 Apr, 2021	4
7 Apr, 2021	S-1MEF
7 Apr, 2021	EFFECT
6 Apr, 2021	S-1/A
5 Apr, 2021	CORRESP
5 Apr, 2021	S-1
5 Apr, 2021	8-K
5 Apr, 2021	CORRESP
1 Apr, 2021	UPLOAD
25 Mar, 2021	DRS
22 Mar, 2021	10-K
2 Mar, 2021	8-K
16 Feb, 2021	SC 13G
11 Feb, 2021	SC 13G
10 Feb, 2021	SC 13G
8 Feb, 2021	SC 13G

Last update:2024-07-15 18:38:37.883291

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.